Among them, the mRNA vaccine is the first nucleic acid vaccine to be vaccinated for the administration of infectious diseases, and may activate both the CD4+ T cell exogenous immune response and the CD8+ T cell endogenous immune response pathways to induce the production of abundant effector and memory CD8+ T cells [120]. Here, CD8A is linked to infectious disease.